Síndrome de Cushing iatrogénico por corticoides inhalados en paciente VIH
| Autor: | Miriam Soto, Francisco Muñoz, Alondra Frías, Carolina Chacón, Alex Ortiz |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Pediatrics
medicine.medical_specialty Tenofovir Pulmonary disease 03 medical and health sciences Cushing syndrome 0302 clinical medicine immune system diseases medicine 030212 general & internal medicine Fluticasone Ritonavir business.industry HIV virus diseases Lamivudine General Medicine medicine.disease Atazanavir Surgery 030228 respiratory system Salmeterol business medicine.drug |
| Zdroj: | Revista médica de Chile v.144 n.7 2016 SciELO Chile CONICYT Chile instacron:CONICYT |
| ISSN: | 0034-9887 |
| Popis: | We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|